Oui Therapeutics is built on science shown to help people manage troubling thoughts.
Oui Therapeutics has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in August 2022.
Oui Therapeutics's investors include First Round Capital, Polaris Partners, CVS Health, Flare Capital Partners, Otsuka Holdings.
Oui Therapeutics is headquartered in New Haven, United States.
Oui Therapeutics is built on science shown to help people manage troubling thoughts.
Oui Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oui Therapeutics — Funding & Investors." VCBacked, August 2, 2022, https://www.vcbacked.co/company/oui-therapeutics. Accessed August 13, 2026.
VCBacked. (2022). Oui Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/oui-therapeutics
{{cite web |title=Oui Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oui-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated